Dolby Laboratories (NYSE:DLB) Updates Q1 2025 Earnings Guidance

Dolby Laboratories (NYSE:DLB) updated its first quarter 2025 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 0.960-1.110 for the period, compared to the consensus estimate of 0.700. The company issued revenue guidance of $330.0 million-$360.0 million, compared to the consensus revenue estimate of $307.9 million. Dolby Laboratories also updated its FY 2025 guidance to 3.990-4.140 EPS.

Dolby Laboratories Stock Down 0.6 %

Shares of DLB stock opened at $70.93 on Wednesday. The firm has a market capitalization of $6.76 billion, a price-to-earnings ratio of 32.39 and a beta of 0.98. Dolby Laboratories has a 12-month low of $66.35 and a 12-month high of $90.06. The firm has a fifty day moving average of $73.69 and a 200-day moving average of $76.01.

Dolby Laboratories announced that its Board of Directors has initiated a stock repurchase program on Wednesday, August 7th that allows the company to repurchase $350.00 million in shares. This repurchase authorization allows the electronics maker to purchase up to 5% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board of directors believes its shares are undervalued.

Wall Street Analyst Weigh In

Several analysts have commented on the stock. Barrington Research restated an “outperform” rating and set a $100.00 target price on shares of Dolby Laboratories in a report on Friday, September 20th. Rosenblatt Securities lifted their target price on Dolby Laboratories from $98.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday. Finally, StockNews.com raised Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a research report on Monday.

Insiders Place Their Bets

In related news, CEO Kevin J. Yeaman sold 28,512 shares of Dolby Laboratories stock in a transaction dated Tuesday, October 15th. The stock was sold at an average price of $74.12, for a total value of $2,113,309.44. Following the sale, the chief executive officer now owns 83,721 shares of the company’s stock, valued at approximately $6,205,400.52. The trade was a 25.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 39.54% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.